Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters

Breast

Volumn 6, Issue 1, 1997, Pages 1-5

  Hamann, U ^a   Costa, S D ^b   Gotte K ^a   Huober, J ^c   Solomayer, E F ^c   Kaufmann, M ^b   Bastert, G ^c   Komitowski, D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER GRADING; CHROMOSOME 17Q; CORRELATION FUNCTION; FEMALE; GENE LOCUS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0031051210     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(97)90534-8     Document Type: Article

References (34)

1. Knudson A G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971: 68: 820-823.
2. Coles C, Thompson A M, Elder P A et al. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 1990; 336: 761-763.
3. Sato T, Tanigami A, Yamakawa K et al. Allelotype of breast cancer: cumulative allele losses promote tumour progression in primary breast cancer. Cancer Res 1990; 50: 7184-7189.
4. Hall J M, Lee M K, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-1689.
5. Narod S A, Feunteun J, Lynch H T et al. Familial breast-ovarian cancer locus on chromosome 17q21-q23. Lancet 1991; 338: 82-83.
6. Easton D F, Bishop D T, Ford D, Crockford G P, the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 1993; 52: 678-701.
7. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
8. Sato T, Saito H, Swensen J et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 1992; 52: 1643-1646.
9. Bevilacqua G, Sobel M E, Liotta L A, Steeg P S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989; 49: 5185-5190.
10. Callahan R, Cropp C, Sheng Z M et al. Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumours. J Cell Biochem 1993; 17: 167-172.
11. Cropp C S, Champeme M-H, Lidereau R, Callahan R. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 1993; 53: 5617-5619.
12. Kirchweger R, Zeillinger R, Schneeberger C, Speiser P, Louason G, Theillet C. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer 1994; 56: 193-199.
13. Mansour E G, Ravdin P M, Dressier L. Prognostic factors in early breast carcinoma. Cancer 1994; 74: 381-400.
14. Costa S D, Kaufmann M, Diel I J et al. Clinically relevant prognostic factors in breast cancer. Klin Lab 1994; 40: 1153-1166.
15. Chen L-C, Neubauer A, Kurisu W et al. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci USA 1991; 88: 3847-3851.
16. Takita K, Sato T, Miyagi M et al. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 1992; 52: 3914-3917.
17. Harada Y, Katagiri T, Ito I et al. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations. Cancer 1994; 74: 2281-2286.
18. Watatani M, Nagayama K, Imanishi Y et al. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy. Breast Cancer Res Treat 1993; 28: 231-239.
19. Thompson A M, Steel C M, Chetty U et al. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer 1990; 61: 74-78.
20. Ito I, Yoshimoto M, Iwase T et al. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 1995; 71: 438-441.
21. Nagai M A, Pacheco M M, Brentani M M, Marques L A, Ponder B A J, Mulligan L M. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. Br J Cancer 1994; 69: 754-758.
22. Devilee P, van Vliet M, van Sloun P et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991; 6: 1705-1711.
23. Weber J L, Kwitek A E, May P E, Wallace M R, Collins F S, Ledbetter D H. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res 1990; 18: 4640.
24. Hall J M, Friedman L, Guenther C et al. Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 1992; 50: 1235-1242.
25. Goldgar D E, Cannon-Albright L A, Oliphant A et al. Chromosomes 17q linkage studies of 18 Utah breast cancer kindreds. Am J Hum Genet 1993; 52: 743-748.
26. Polymeropoulos M H, Rath D S, Xiao H, Merrill C R. A simple sequence repeat polymorphism at the human growth hormone locus. Nucleic Acids Res 1991; 19: 689.
27. Weissenbach J, Gyapay G, Dib C et al. A second-generation linkage map of the human genome. Nature 1992; 359: 794-801.
28. Weber J L, May P E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989; 44: 388-396.
29. Hamann U, Herbold C, Costa S et al. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res 1996; 56: 1988-1990.
30. Chen L-C, Kurisu W, Ljung B-M, Goldman E S, Moore II D, Smith H S. Heterogeneity for allelic loss in human breast cancer. JNCI 1992; 84: 506-510.
31. Devilee P, Schuuring E, van de Vijver M J, Cornelisse C J. Recent developments in the molecular genetic understanding of breast cancer. Crit Rev Oncogen 1994; 5 (2&3): 247-270.
32. Futreal P A, Söderkvist P, Marks J R et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 1992; 52: 2624-2627.
33. Futreal P A, Lui Q, Shattuck-Eidens D et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-122.
34. Nomura Y, Miura S, Koyama H et al. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer, A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer. Cancer 1992; 69(1): 153-164.